1. Home
  2. UFPT vs IOVA Comparison

UFPT vs IOVA Comparison

Compare UFPT & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UFP Technologies Inc.

UFPT

UFP Technologies Inc.

HOLD

Current Price

$192.02

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$3.43

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UFPT
IOVA
Founded
1963
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
1996
2008

Fundamental Metrics

Financial Performance
Metric
UFPT
IOVA
Price
$192.02
$3.43
Analyst Decision
Buy
Buy
Analyst Count
2
10
Target Price
$289.00
$9.11
AVG Volume (30 Days)
155.3K
14.3M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
15.44
14.84
EPS
8.75
N/A
Revenue
$602,797,000.00
N/A
Revenue This Year
$8.12
$51.55
Revenue Next Year
$5.72
$37.55
P/E Ratio
$21.93
N/A
Revenue Growth
19.50
N/A
52 Week Low
$178.26
$1.64
52 Week High
$274.93
$5.63

Technical Indicators

Market Signals
Indicator
UFPT
IOVA
Relative Strength Index (RSI) 37.12 44.16
Support Level $185.63 $2.02
Resistance Level $206.13 $4.34
Average True Range (ATR) 7.90 0.25
MACD 1.31 -0.11
Stochastic Oscillator 28.56 19.21

Price Performance

Historical Comparison
UFPT
IOVA

About UFPT UFP Technologies Inc.

UFP Technologies Inc is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. The company manufactures its products by converting raw materials using laminating, molding, radio frequency, and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: